Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study

@article{Miroslawska2016RenalSD,
  title={Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study},
  author={Atena K Miroslawska and Marit Dahl Solbu and Eystein Skj\olsvik and Ingrid Toft and Terje Kristian Steigen},
  journal={Journal of Human Hypertension},
  year={2016},
  volume={30},
  pages={153-157}
}
Renal sympathetic denervation (RDN) represents a potential treatment option for highly selected patients with resistant arterial hypertension. In this open label study, we aimed to investigate the response of blood pressure (BP) and short-term BP variability (BPV) to RDN 6 months after procedure. We defined treatment-resistant hypertension as office systolic BP>140 mm Hg, despite maximum tolerated doses of ⩾4 antihypertensive drugs, including a diuretic. In addition, daytime systolic ambulatory… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 36 references

: Six - Month Results From the Prague - 15 Study

FE FadlElmula, P Hoffmann, +3 authors U Hjornholm
2014

: con side of the argument

A Persu, M Azizi, +3 authors FE FadlElmula
2014

Similar Papers

Loading similar papers…